Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithymocyte Globulin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00731328
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesNonmalignant Neoplasm+1 more
Asan Medical Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT01624805
What this trial is testing

Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

Who this might be right for
Aplastic Anemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+1 more
M.D. Anderson Cancer Center 140
Not applicableUnknownNCT06039436
What this trial is testing

Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT

Who this might be right for
Severe Aplastic Anemia
Anhui Provincial Hospital 72
Testing effectiveness (Phase 2)Study completedNCT01390402
What this trial is testing

Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

Who this might be right for
LeukemiaChronic Myelogenous Leukemia
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT04291703
What this trial is testing

STOP-T1D Low-Dose (ATG)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2
Post-approval studies (Phase 4)Ended earlyNCT02056938
What this trial is testing

ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF

Who this might be right for
Kidney Transplantation
Nantes University Hospital 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04202835
What this trial is testing

ATG Plus PTCy vs ATG for CGVHD Prophylaxis

Who this might be right for
Acute LeukemiaMyelodysplasiaChronic Graft-versus-host-disease
McMaster University 80
Testing effectiveness (Phase 2)UnknownNCT01509300
What this trial is testing

HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromeSolid Tumors
Asan Medical Center 10
Post-approval studies (Phase 4)Study completedNCT00556933
What this trial is testing

Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

Who this might be right for
End-stage Renal Disease
University of Nebraska 180
Early research (Phase 1)Study completedNCT00010335
What this trial is testing

Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

Who this might be right for
Systemic SclerosisSystemic Lupus ErythematosusDermatomyositis+2 more
Fred Hutchinson Cancer Center 6
Early research (Phase 1)Study completedNCT01471067
What this trial is testing

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma+2 more
M.D. Anderson Cancer Center 33
Large-scale testing (Phase 3)Ended earlyNCT06108739
What this trial is testing

ATG Plus Low-dose PT-Cy for GVHD Prevention

Who this might be right for
Hematologic Malignancy
Peking University People's Hospital 66
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Large-scale testing (Phase 3)UnknownNCT00934557
What this trial is testing

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

Who this might be right for
Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer
Fondazione IRCCS Policlinico San Matteo di Pavia 42
Testing effectiveness (Phase 2)Looking for participantsNCT07508787
What this trial is testing

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

Who this might be right for
Renal Transplant Failure and Rejection
Nefro Avillion Clinical Development, LLC 120
Testing effectiveness (Phase 2)Study completedNCT00630253
What this trial is testing

Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia

Who this might be right for
Fanconi Anemia
Masonic Cancer Center, University of Minnesota 31
Testing effectiveness (Phase 2)Ended earlyNCT00506948
What this trial is testing

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Who this might be right for
Hematological MalignanciesMyelodysplastic SyndromeLeukemia+1 more
M.D. Anderson Cancer Center 13
Large-scale testing (Phase 3)Study completedNCT01471444
What this trial is testing

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Disorder Related to Bone Marrow TransplantationLeukemiaTransplantation Infection
M.D. Anderson Cancer Center 256
Testing effectiveness (Phase 2)Study completedNCT00217386
What this trial is testing

Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01105273
What this trial is testing

Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia

Who this might be right for
Aplastic Anemia
Asan Medical Center 12
Next Page